Democrats support germline genetic engineering
Lev Facher, 6-18-2019, (Lev Facher is a Washington correspondent for STAT, reporting on the politics of health and science. Since joining STAT in 2016, he has written extensively about the federal government’s response to the Covid-19 pandemic, the opioid crisis, and the pharmaceutical industry’s influence on Capitol Hill.) "Why Democrats reopened the debate about germline gene editing", STAT, https://www.statnews.com/2019/06/18/democrats-reopened-debate-about-germline-editing/ lilw-msdi2022
WASHINGTON — A rogue Chinese scientist stunned the world last year when he announced the birth of genetically modified twin girls, prompting widespread outcry from the broader scientific community and calls for a “global moratorium” on editing human embryos that result in births. Yet months later, Democrats on Capitol Hill surprised many science policy experts when they attempted to roll back a related, 4-year-old ban on altering the DNA of embryos intended for pregnancies. To many health policy experts here, and research advocates across the country, the timing — just months after the biggest genome editing scandal in world history — was inexplicable. Several Republicans criticized the proposal by playing up concerns of “maverick bioengineers” operating with little oversight and without ethical norms. And while some scientists supported the effort, others expressed open confusion, in particular at the breadth of the change Democrats sought. Within weeks of proposing to eliminate their plan, Democrats largely backed off. But their sudden effort to reverse what seemed to some like a basic ethical protection serves as a case study in how Washington regulates science — and the immense influence lawmakers, regardless of their scientific expertise, often wield over federal research. “In terms of ‘Why now,’ it does seem odd given there is so much international conversation in the scientific community about how to limit germline editing,” said Remy Brim, a scientist and former Democratic Capitol Hill aide who works at the D.C. lobbying firm BGR. The United States has banned germline editing with the aim of starting a pregnancy since 2015, the result of bipartisan opposition to the practice and preemptive scientific concern about the implications of the gene-editing technology CRISPR. Republicans in particular have supported the ban due to conscience concerns similar to those surrounding the use of fetal tissue in research and using federal funds for abortion — some argue that germline genome editing requires the creation of human embryos that will eventually be discarded. When Democrats took control of the House of Representatives in last year’s midterm elections, they saw an opening to repeal a measure that many felt was overly restrictive. As the House Appropriations Committee considered the spending package that funds the Food and Drug Administration, lawmakers excluded the brief provision that has banned the consideration of certain genome-editing trials — a change that would have essentially lifted the ban, if the law had passed. Republicans quickly criticized the change, calling it hasty and ill-advised — even specifically citing China’s “CRISPR babies” scandal, in which He Jiankui drew worldwide criticism for using the technique to alter the genes of twin girls.